Table 1 Table of mean, standard deviation and median values of ICCs for each sample, reactivity model, and ROI.

From: Correction: Importance of test–retest reliability for promoting fMRI based screening and interventions in major depressive disorder

Population

Reactivity model

Amygdala

DLPFC

rACC

sgACC liberally thresholded

sgACC conservatively thresholded

Controls & patients

Canonical amplitude

0.11 (±0.09); 0.11

0.24 (±0.16); 0.26

0.09 (±0.10); 0.09

0.15 (±0.08); 0.13

0.17 (±0.09); 0.18

Amplitude

0.23 (±0.14); 0.22

0.12 (±0.11); 0.12

0.11 (±0.10); 0.12

−0.01 (±0.13); −0.04

−0.04 (±0.14); −0.08

Area under the curve

0.13 (±0.14); 0.12

0.08 (±0.10); 0.07

0.03 (±0.11); 0.03

−0.03 (±0.09); −0.04

−0.06 (±0.10); −0.07

Onset delay

0 (±0.09); −0.01

0.01 (±0.09); 0

0 (±0.10); 0

0 (±0.08); 0.01

−0.01 (±0.10); 0

Rise decay

0 (±0); 0

0 (±0); 0

0 (±0); 0

0 (±0); 0

0 (±0); 0

Height

0.08 (±0.10); 0.09

0.21 (±0.15); 0.23

0.13 (±0.12); 0.14

0.16 (±0.12); 0.17

0.18 (±0.12); 0.23

Patients

Canonical amplitude

0.09(±0.11); 0.11

0.22 (±0.16); 0.23

0.08 (±0.14); 0.08

0.10 (±0.12); 0.07

0.14 (±0.15); 0.12

Amplitude

0.22 (±0.15); 0.22

0.11 (±0.13); 0.11

0.10 (±0.13); 0.11

−0.06 (±0.15); −0.07

−0.08 (±0.14); −0.08

Area under the curve

0.13 (±0.14); 0.12

0.6 (±0.12); 0.03

0.03 (±0.13); 0.04

−0.08 (±0.13); −0.08

−0.10 (±0.13); −0.09

Onset delay

−0.01 (±0.12); −0.01

0.01 (±0.12); 0

−0.01 (±0.13); −0.01

0.02 (±0.11); 0.02

0.01 (±0.12); 0.05

Rise decay

0 (±0); 0

0 (±0); 0

0 (±0); 0

0 (±0); 0

0 (±0); 0

Height

0.09 (±0.12); 0.08

0.22 (±0.16); 0.23

0.12 (±0.15); 0.13

0.16 (±0.17); 0.18

0.17 (±0.17); 0.21

  1. Mean (±standard deviation); median.